Table 3.
Visual acuity at one month.
| Bevacizumab group | Untreated group | p value | |
|---|---|---|---|
| Preoperative | HM | HM | p = 0.3049 |
| One month postoperative | 20/300 | 20/200 | p = 0.594 |
| Difference in LogMAR | −1.014 | −0.8790 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.